Malcolm A. Martin

6.6k total citations
70 papers, 4.6k citations indexed

About

Malcolm A. Martin is a scholar working on Virology, Immunology and Epidemiology. According to data from OpenAlex, Malcolm A. Martin has authored 70 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Virology, 43 papers in Immunology and 28 papers in Epidemiology. Recurrent topics in Malcolm A. Martin's work include HIV Research and Treatment (55 papers), Immune Cell Function and Interaction (37 papers) and Herpesvirus Infections and Treatments (17 papers). Malcolm A. Martin is often cited by papers focused on HIV Research and Treatment (55 papers), Immune Cell Function and Interaction (37 papers) and Herpesvirus Infections and Treatments (17 papers). Malcolm A. Martin collaborates with scholars based in United States, Poland and France. Malcolm A. Martin's co-authors include Alicia Buckler‐White, Yoshiaki Nishimura, Tatsuhiko Igarashi, Arnold B. Rabson, Ronald J. Plishka, Olivia K. Donau, H. Clifford Lane, Elizabeth K. Ross, Reza Sadjadpour and Riri Shibata and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Malcolm A. Martin

68 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malcolm A. Martin United States 38 3.6k 2.4k 1.7k 1.0k 868 70 4.6k
Jesus F. Salazar-Gonzalez United States 20 3.9k 1.1× 2.1k 0.9× 2.0k 1.2× 1.1k 1.1× 1.0k 1.2× 36 5.1k
Éva Mária Fenyõ Sweden 38 3.5k 1.0× 1.9k 0.8× 2.2k 1.3× 923 0.9× 741 0.9× 116 4.6k
T J Palker United States 28 3.0k 0.8× 2.9k 1.2× 1.6k 1.0× 1.1k 1.1× 887 1.0× 53 5.4k
Gianfranco Pancino France 35 3.4k 0.9× 2.6k 1.1× 1.4k 0.8× 1.3k 1.3× 925 1.1× 100 4.8k
Yves Rivière France 39 2.9k 0.8× 2.5k 1.1× 1.6k 0.9× 1.2k 1.2× 1.1k 1.3× 124 4.9k
P Di Marzio United States 12 3.4k 0.9× 2.4k 1.0× 1.5k 0.9× 758 0.7× 1.1k 1.3× 17 4.6k
Robin A. Weiss United Kingdom 20 3.0k 0.8× 2.5k 1.1× 1.5k 0.9× 920 0.9× 969 1.1× 40 5.0k
Jacqueline D. Reeves United States 31 2.9k 0.8× 1.8k 0.7× 2.9k 1.7× 1.1k 1.0× 883 1.0× 62 5.2k
Ghalib Alkhatib United States 24 2.8k 0.8× 2.5k 1.1× 1.2k 0.7× 886 0.9× 882 1.0× 38 4.4k
C. David Pauza United States 42 2.9k 0.8× 3.3k 1.4× 1.4k 0.8× 1.2k 1.2× 972 1.1× 145 5.7k

Countries citing papers authored by Malcolm A. Martin

Since Specialization
Citations

This map shows the geographic impact of Malcolm A. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm A. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm A. Martin more than expected).

Fields of papers citing papers by Malcolm A. Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malcolm A. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm A. Martin. The network helps show where Malcolm A. Martin may publish in the future.

Co-authorship network of co-authors of Malcolm A. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm A. Martin. A scholar is included among the top collaborators of Malcolm A. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm A. Martin. Malcolm A. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gristick, Harry B., Harald Hartweger, Yoshiaki Nishimura, et al.. (2025). Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes. The Journal of Experimental Medicine. 222(10).
2.
Nishimura, Yoshiaki, Thiago Y. Oliveira, Marie Canis, et al.. (2025). Clonal expansion and diversification of germinal center and memory B cell responses to booster immunization in primates. Cell Reports. 44(8). 116142–116142.
3.
Dias, Joana, Giulia Fabozzi, Mangaiarkarasi Asokan, et al.. (2021). Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent staging. Journal of Clinical Investigation. 131(17). 4 indexed citations
4.
Abernathy, Morgan E., Harry B. Gristick, Jost Vielmetter, et al.. (2021). Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope. npj Vaccines. 6(1). 126–126. 3 indexed citations
5.
Nishimura, Yoshiaki, James N. Francis, Olivia K. Donau, et al.. (2020). Prevention and treatment of SHIVAD8 infection in rhesus macaques by a potent d -peptide HIV entry inhibitor. Proceedings of the National Academy of Sciences. 117(36). 22436–22442. 19 indexed citations
6.
Nishimura, Yoshiaki, Olivia K. Donau, Joana Dias, et al.. (2020). Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia. The Journal of Experimental Medicine. 218(1). 37 indexed citations
7.
Wagh, Kshitij, Michael S. Seaman, Dan H. Barouch, et al.. (2018). Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections. PLoS Pathogens. 14(3). e1006860–e1006860. 57 indexed citations
8.
Gautam, Rajeev, Yoshiaki Nishimura, Anna Gazumyan, et al.. (2018). A single injection of crystallizable fragment domain–modified antibodies elicits durable protection from SHIV infection. Nature Medicine. 24(5). 610–616. 83 indexed citations
10.
Gautam, Rajeev, Yoshiaki Nishimura, W. Robert Lee, et al.. (2012). Pathogenicity and Mucosal Transmissibility of the R5-Tropic Simian/Human Immunodeficiency Virus SHIV AD8 in Rhesus Macaques: Implications for Use in Vaccine Studies. Journal of Virology. 86(16). 8516–8526. 35 indexed citations
11.
Walker, Laura M., Devin Sok, Yoshiaki Nishimura, et al.. (2011). Rapid development of glycan-specific, broad, and potent anti–HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque. Proceedings of the National Academy of Sciences. 108(50). 20125–20129. 60 indexed citations
12.
Willey, Ronald L., Martha Nason, Yoshiaki Nishimura, Dean Follmann, & Malcolm A. Martin. (2010). Neutralizing Antibody Titers Conferring Protection to Macaques from a Simian/Human Immunodeficiency Virus Challenge Using the TZM-bl Assay. AIDS Research and Human Retroviruses. 26(1). 89–98. 33 indexed citations
13.
Lafont, Bernard A. P., Christopher M. McGraw, Alicia Buckler‐White, et al.. (2007). The locus encoding an oligomorphic family of MHC-A alleles (Mane-A*06/Mamu-A*05) is present at high frequency in several macaque species. Immunogenetics. 59(3). 211–223. 16 indexed citations
14.
Lafont, Bernard A. P., Tatsuhiko Igarashi, Yoshiaki Nishimura, et al.. (2005). CD8+and CD20+Lymphocytes Cooperate To Control Acute Simian Immunodeficiency Virus/Human Immunodeficiency Virus Chimeric Virus Infections in Rhesus Monkeys: Modulation by Major Histocompatibility Complex Genotype. Journal of Virology. 79(23). 14887–14898. 30 indexed citations
15.
Lafont, Bernard A. P., Alicia Buckler‐White, Ron Plishka, Charles E. Buckler, & Malcolm A. Martin. (2004). Pig-tailed macaques (Macaca nemestrina) possess six MHC-E families that are conserved among macaque species: implication for their binding to natural killer receptor variants. Immunogenetics. 56(3). 142–154. 15 indexed citations
16.
Lafont, Bernard A. P., Alicia Buckler‐White, Ron Plishka, Charles E. Buckler, & Malcolm A. Martin. (2003). Characterization of Pig-Tailed Macaque Classical MHC Class I Genes: Implications for MHC Evolution and Antigen Presentation in Macaques. The Journal of Immunology. 171(2). 875–885. 27 indexed citations
17.
Sodora, Donald L., Daniel C. Douek, Guido Silvestri, et al.. (2000). Quantification of thymic function by measuring T cell receptor excision circles within peripheral blood and lymphoid tissues in monkeys. European Journal of Immunology. 30(4). 1145–1153. 71 indexed citations
18.
Igarashi, Tatsuhiko, Yasuyuki Endo, G Englund, et al.. (1999). Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus. Proceedings of the National Academy of Sciences. 96(24). 14049–14054. 66 indexed citations
19.
Kharroubi, Aboubaker El, et al.. (1998). Transcriptional Activation of the Integrated Chromatin-Associated Human Immunodeficiency Virus Type 1 Promoter. Molecular and Cellular Biology. 18(5). 2535–2544. 122 indexed citations
20.
Khoury, George & Malcolm A. Martin. (1972). Comparison of SV40 DNA Transcription in vivo and in vitro. Nature New Biology. 238(79). 4–6. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026